Future Science Group
Browse
Supplemental Material_Figure.docx (175.54 kB)

Supplemental Material Figure - Real-World Clinical Outcomes of Patients With Myelofibrosis Treated With Ruxolitinib: a Medical Record Review

Download (175.54 kB)
figure
posted on 2022-04-14, 10:44 authored by Francesco Passamonti, Florian H. Heidel, Rohan C. Parikh, Mayank Ajmera, Derek Tang, Jose Alberto Nadal, Keith L. Davis, Pranav Abraham

Supplemental Figure 1: Median Overall Survival From Ruxolitinib Based on Total Daily Dose at Initiation

Funding

Bristol-Myers Squibb

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC